WP
MBX

Woodline Partners’s MBX Biosciences MBX Stock Holding History

Woodline Partners’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.7M Buy
900,092
+29
+0% +$1.01K 0.15% 175
2026
Q1 		$26.9M Sell
900,063
-100,000
-10% -$3.4M 0.1% 271
2025
Q4 		$31.5M Sell
1,000,063
-201,087
-17% -$4.88M 0.12% 215
2025
Q3 		$21M Buy
1,201,150
+300,047
+33% +$4.01M 0.1% 272
2025
Q2 		$10.3M Buy
901,103
+23,642
+3% +$241K 0.05% 429
2025
Q1 		$6.48M Buy
877,461
+268,740
+44% +$2.84M 0.04% 442
2024
Q4 		$11.2M Buy
608,721
+89,046
+17% +$1.9M 0.08% 315
2024
Q3 		$13.5M Buy
+519,675
New +$11.9M 0.11% 245

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Woodline Partners's MBX Position: Q2 2026 in Review

Woodline Partners increased its MBX Biosciences (MBX) stake by 0% in Q2 2026, buying an estimated $1.01K and bringing the position to 900,092 shares worth $49.7M. The position accounts for 0.15% of the portfolio, ranked #175.

Woodline Partners first reported a position in MBX in Q3 2024 and has held it in 8 quarters since. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Woodline Partners held 900,092 shares of MBX Biosciences worth $49.7M as of Q2 2026.
  • Woodline Partners bought 29 MBX Biosciences shares in Q2 2026, an estimated $1.01K.
  • MBX Biosciences made up 0.15% of Woodline Partners's portfolio in Q2 2026, its #175 holding.
  • Woodline Partners first reported a position in MBX Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.